author-photo

Carl Diedrich Schlenkhoff

University Hospital Bonn

15

Papers

419

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Lutetium-177-PSMA-Radioligandentherapie: Konsensus im Rahmen der GKV-finanzierten Versorgung zwischen den Hochschulkliniken in Aachen, Bonn, Düsseldorf, Essen und Köln und dem MDK Nordrhein

2018 Urologe A
Show All
- Source
- Cite
- Save
Citations (0)
Possible Treatment Approach to an Extravasation of 177Lu-PSMA-617

2017 Clinical Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (7)
Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [ 177 Lu]Lu-PSMA-617 radioligand therapy

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (46)
[18F]Fluorodeoxyglucose positron emission tomography reveals a complete remission of refractory metastatic melanoma after therapy with ipilimumab

2017 Indian Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer.

2016 Clinical Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (18)
68Ga-Labeled Anti-Prostate-Specific Membrane Antigen Peptide as Marker for Androgen Deprivation Therapy Response in Prostate Cancer.

2016 Clinical Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (10)
Metastatic Prostate Cancer With Restored Hormone-Response After Radioligand Therapy With 177Lu-PSMA-617.

2016 Clinical Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (12)
68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer.

2016 Clinical Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (12)
Bestimmung der Absolutzahl von Lymphozytensubtypen im peripheren Blut

2008
- Carl Diedrich Schlenkhoff
Show All
- Source
- Cite
- Save
Citations (0)